Common use of Future Reports to the Representatives Clause in Contracts

Future Reports to the Representatives. During the period of five years hereafter the Company will furnish or make available to Stifel at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: Capital Markets, and to JMP at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100, San Francisco, CA 94111, Attention: Capital Markets: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed generally to holders of its capital stock; provided that the requirements of this subsection (p) shall be satisfied to the extent the reports, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 2 contracts

Sources: Underwriting Agreement (Horizon Pharma, Inc.), Underwriting Agreement (Horizon Pharma, Inc.)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at the Representatives, c/o Cowen and Company, LLC, ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇., ▇▇▇ ▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Head of Equity Capital Markets with a copy to c/o Barclays Capital Inc., ▇▇ ▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital Markets, and to JMP at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100, San Francisco, CA 94111, Attention: Capital Markets: Syndicate Registration: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 2 contracts

Sources: Underwriting Agreement (Mirati Therapeutics, Inc.), Underwriting Agreement (Mirati Therapeutics, Inc.)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at ▇▇▇ the Representatives, c/o ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at 5▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsGlobal Head of Syndicate and c/o Barclays, and to JMP at ▇7▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100▇▇▇ ▇▇▇▇, San Francisco, CA 94111▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsSyndicate Registration (Fax: (▇▇▇) ▇▇▇-▇▇▇▇): (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on E▇▇▇▇.

Appears in 2 contracts

Sources: Placement Agency Agreement (Advaxis, Inc.), Underwriting Agreement (Advaxis, Inc.)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel the Representatives, c/o Jefferies LLC, at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsGlobal Head of Syndicate, and to JMP c/o Cowen and Company, LLC, at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100▇▇▇▇ ▇▇▇▇▇, San Francisco▇▇▇ ▇▇▇▇, CA 94111, Attention: Capital Markets▇▇▇ ▇▇▇▇ ▇▇▇▇▇: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 2 contracts

Sources: Underwriting Agreement (Glycomimetics Inc), Underwriting Agreement (Glycomimetics Inc)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at ▇▇the Representatives, c/▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsGlobal Head of Syndicate, and to JMP at c/o Leerink Partners LLC, ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100, San Francisco, CA 94111, Attention: Capital Markets: Syndicate Department (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 2 contracts

Sources: Underwriting Agreement (Aclaris Therapeutics, Inc.), Underwriting Agreement (Aclaris Therapeutics, Inc.)

Future Reports to the Representatives. During the period of five years hereafter one year hereafter, the Company will furnish or make available to Stifel at ▇▇the Representatives, c/▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsGlobal Head of Syndicate and c/o Morgan ▇▇▇▇▇▇▇, and to JMP at ▇▇▇ ▇▇▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇, Suite 1100, San Francisco, CA 94111, Attention: Capital Markets: Equity Syndicate Desk, (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholdersshareholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stockshares of beneficial interest; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇ or otherwise publicly disseminated.

Appears in 2 contracts

Sources: Underwriting Agreement (National Storage Affiliates Trust), Underwriting Agreement (National Storage Affiliates Trust)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel the Representatives, c/o Jefferies LLC, at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsGlobal Head of Syndicate, and to JMP at c/o Leerink ▇▇▇▇▇ LLC, ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100, San Francisco, CA 94111, Attention: Capital Markets: General Counsel: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(q) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 2 contracts

Sources: Underwriting Agreement (Mirati Therapeutics, Inc.), Underwriting Agreement (Mirati Therapeutics, Inc.)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇the Representatives, Suite 3700c/o Citigroup Global Markets Inc., San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital Markets, ECM-Syndicate Desk and to JMP at ▇▇c/▇ ▇▇▇▇▇▇▇▇▇ LLC, ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100▇▇▇ ▇▇▇▇, San Francisco, CA 94111▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsGlobal Head of Syndicate: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other public report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 2 contracts

Sources: Underwriting Agreement (Bellicum Pharmaceuticals, Inc), Underwriting Agreement (Bellicum Pharmaceuticals, Inc)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at ▇▇▇ the Representatives, c/o ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at 5▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsGlobal Head of Syndicate; c/o Evercore, and to JMP at ▇▇5▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100▇▇▇ ▇▇▇▇, San Francisco, CA 94111▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsECM General Counsel: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(n) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on E▇▇▇▇.

Appears in 2 contracts

Sources: Underwriting Agreement (Astria Therapeutics, Inc.), Underwriting Agreement (Astria Therapeutics, Inc.)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at ▇▇the Representatives c/▇ ▇▇▇▇▇▇▇▇▇▇▇▇▇▇LLC, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsGlobal Head of Equity Syndicate and c/o Leerink Partners LLC, and to JMP at ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100, San Francisco, CA 94111, Attention: Capital MarketsSyndicate Department: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholdersshareholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other similar report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stockshares; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Wave Life Sciences Pte LTD)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at ▇▇the Representatives, c/▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsGlobal Head of Syndicate, and to JMP c/o Merrill ▇▇▇▇▇ at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇, Suite 1100, San Francisco, CA 94111▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsSyndicate Department, with a copy to ECM Legal: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other public report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (ProNAi Therapeutics Inc)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at ▇▇▇ the Representatives, c/o ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at 5▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsGlobal Head of Syndicate, and to JMP at c/o P▇▇▇▇ ▇▇▇▇▇▇▇, at 3▇▇ ▇▇▇▇ ▇▇▇, ▇▇▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇, Suite 1100, San Francisco, CA 94111, Attention: Equity Capital Markets: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statements, communications, financial statements or other documents referenced herein are available on E▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (TELA Bio, Inc.)

Future Reports to the Representatives. During the period of five (5) years hereafter the Company will furnish or make available to Stifel at NationsBanc Mont▇▇▇▇▇▇ ▇▇▇urities, Inc., at 600 ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, 94111 Attention: Syndicate, to Cowen at Clar▇ ▇▇▇▇▇▇▇▇ ▇▇▇ to Cowe▇ & ▇ompany, 4 Em▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: Capital Markets, and to JMP at ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ ▇▇▇ention: Jeff▇▇▇ ▇▇▇▇▇▇, Suite 1100, San Francisco, CA 94111, Attention: Capital Markets: : (i) as soon as reasonably practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders' equity and cash flows for the year then ended and the opinion thereon of the Company’s 's independent public or certified public accountants; (ii) as soon as reasonably practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA the NASD or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed generally to holders of its capital stock; provided that the requirements of this subsection (p) shall be satisfied to the extent the reports, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Spectra Physics Lasers Inc)

Future Reports to the Representatives. During the period of five three years hereafter hereafter, the Company will furnish or make available to Stifel at ▇▇▇ ▇the Representatives, c/o ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇LLC, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇520 M▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: Capital Markets, and to JMP at ▇▇▇ ▇▇▇▇▇, ▇▇▇ention: Global Head of Syndicate and c/o Leerink Partners LLC, 53 St▇▇▇ ▇▇▇▇▇▇, Suite 1100▇▇▇▇ ▇▇▇▇▇, San Francisco▇▇▇▇▇▇, CA 94111▇▇ ▇▇▇▇▇, Attention▇▇▇ention: Capital MarketsSyndicate Department: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on E▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Celldex Therapeutics, Inc.)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at ▇▇the Representatives, c/▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsGlobal Head of Syndicate and c/o Cowen, and to JMP at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100▇▇▇▇ ▇▇▇▇▇, San Francisco▇▇▇ ▇▇▇▇, CA 94111▇▇▇ ▇▇▇▇, ▇▇▇▇▇, Attention: Capital Markets: General Counsel: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Codexis Inc)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel the Representatives c/o Cowen and Company, LLC, at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇5▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: General Counsel; and Cantor F▇▇▇▇▇▇▇▇▇ & Co. at 4▇▇ ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital Markets, and with a copy to JMP at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100, San Francisco, CA 94111, Attention: Capital Markets: General Counsel (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other public report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on E▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Marinus Pharmaceuticals Inc)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at ▇▇the Representatives, c/▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsGlobal Head of Syndicate and Credit Suisse Securities (USA) LLC, and to JMP at ▇▇▇ ▇▇▇Eleven ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100▇▇▇ ▇▇▇▇, San Francisco, CA 94111▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsIBCM-Legal: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Progenics Pharmaceuticals Inc)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at ▇▇▇ the Representatives, c/o ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at 5▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital Markets, Global Head of Syndicate and to JMP at c/o Raymond J▇▇▇▇ & Associates, Inc., 8▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100▇▇. ▇▇▇▇▇▇▇▇▇▇, San Francisco, CA 94111▇▇▇▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsGeneral Counsel: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on E▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Adma Biologics, Inc.)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at the Representatives, c/o Jefferies LLC, ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Global Head of Syndicate and ▇/▇ ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ & Company, Incorporated, ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA California 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: Capital Markets, and to JMP at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100, San Francisco, CA 94111, Attention: Capital MarketsSyndicate Department: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(A)(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (TherapeuticsMD, Inc.)

Future Reports to the Representatives. During the period of five years hereafter one year hereafter, the Company will furnish or make available to Stifel at ▇▇the Representatives, c/▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsGlobal Head of Syndicate, and to JMP c/o Morgan ▇▇▇▇▇▇▇, at ▇▇▇ ▇▇▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇, Suite 1100, San Francisco, CA 94111, Attention: Capital Markets: Equity Syndicate Desk, (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholdersshareholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stockshares of beneficial interest; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇ or otherwise publicly disseminated.

Appears in 1 contract

Sources: Underwriting Agreement (National Storage Affiliates Trust)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at ▇▇the Representatives, c/▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsGlobal Head of Syndicate, and to JMP at c/o SVB Leerink LLC 1301 Avenue of the ▇▇▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇, Suite 1100, San Francisco, CA 94111, Attention: Capital MarketsGlobal Head of Syndicate: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Relmada Therapeutics, Inc.)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at ▇▇the Representatives, c/▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsGlobal Head of Syndicate, and to JMP c/o ▇▇▇▇▇ ▇▇▇▇▇▇▇, at ▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100, San Francisco, CA 94111, Attention: Capital MarketsProspectus Delivery Department: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other public report filed by the Company with the Commission, FINRA or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (OptiNose, Inc.)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel the Representatives, c/o Jefferies LLC, at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsGlobal Head of Syndicate, and to JMP c/o Barclays Capital Inc., at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100▇▇▇ ▇▇▇▇, San Francisco, CA 94111▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital Markets: Syndicate Registration: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(q) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Glycomimetics Inc)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at the Representatives c/o ▇.▇. ▇▇▇▇▇▇ Securities LLC, ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: Capital MarketsEquity Syndicate Desk, and to JMP at c/o Leerink Partners LLC, ▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100, San Francisco, CA 94111, Attention: Capital MarketsSyndicate Department: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholdersshareholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other similar report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stockshares; provided provided, however, that the requirements of this subsection (pSection 3(q) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Wave Life Sciences Ltd.)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel the Representatives, c/o Brean, at 1345 Avenue of the ▇▇▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Chief Executive Officer, and c/o Imperial at 2000 Ave of the Stars, ▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: Capital Markets, and to JMP at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100, San Francisco, CA 94111, Attention: Capital Markets: Chief Operating Officer (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(A)(q) shall be satisfied to the extent the that such reports, statements, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (ARC Group Worldwide, Inc.)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at ▇▇the Representatives, c/▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsGlobal Head of Syndicate, and to JMP c/▇ ▇▇▇▇▇, at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100▇▇▇▇ ▇▇▇▇▇, San Francisco▇▇▇ ▇▇▇▇, CA 94111▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital Markets: General Counsel: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Kezar Life Sciences, Inc.)

Future Reports to the Representatives. During the period of five years hereafter one year hereafter, the Company will furnish or make available to Stifel the Representatives, c/o Wells Fargo, at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇. ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇, Attention: Capital Markets, and to JMP at ▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100, San Francisco, CA 94111, Attention: Capital MarketsEquity Syndicate and c/o Morgan ▇▇▇▇▇▇▇, at ▇▇▇▇ ▇▇▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Equity Syndicate Desk, (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholdersshareholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stockshares of beneficial interest; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇ or otherwise publicly disseminated.

Appears in 1 contract

Sources: Underwriting Agreement (National Storage Affiliates Trust)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel the Representatives, c/o Jefferies LLC, at ▇▇52▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsGlobal Head of Syndicate and Guggenheim Securities, and to JMP LLC, at ▇▇33▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100▇▇▇ ▇▇▇▇, San Francisco, CA 94111▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsMarkets Syndicate: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholdersshareholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other similar report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stockshare capital; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Axovant Sciences Ltd.)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at the Representatives c/o ▇.▇. ▇▇▇▇▇▇ Securities LLC, ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Equity Syndicate Desk, and c/o Leerink Partners LLC, ▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: Capital Markets, and to JMP at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100, San Francisco, CA 94111, Attention: Capital MarketsSyndicate Department: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholdersshareholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other similar report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stockshares; provided provided, however, that the requirements of this subsection (pSection 3(q) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Wave Life Sciences Ltd.)

Future Reports to the Representatives. During the period of five three years hereafter hereafter, the Company will furnish or make available to Stifel at ▇▇the Representatives, c/▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital Markets, Global Head of Syndicate and to JMP at ▇▇▇ ▇▇▇▇▇c/o ▇▇▇▇▇ ▇▇▇▇▇▇▇ & Co., Suite 1100▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇, San Francisco▇▇▇▇▇ ▇▇▇▇, CA 94111▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Equity Capital Markets: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (CareDx, Inc.)

Future Reports to the Representatives. During the period of five years hereafter the Company will furnish or make available to Stifel the Representatives at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: Capital Markets, and to JMP at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100, San Francisco, CA 94111, Attention: Capital Marketsthe addresses set forth in Section 15: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided that the requirements of this subsection (p) shall be satisfied to the extent the reports, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Vical Inc)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at ▇▇▇ the Representatives, c/o ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at 5▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsGlobal Head of Syndicate, and to JMP c/o SVB Leerink, at 1▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100▇▇▇▇ ▇▇▇▇▇, San Francisco▇▇▇ ▇▇▇▇, CA 94111▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital Markets: General Counsel: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on E▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Cryoport, Inc.)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at ▇▇the Representatives, c/o BMO Capital Markets Corp., ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: Equity Capital MarketsMarkets Syndicate Desk and c/o Wells Fargo Securities, and to JMP at LLC, ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100▇▇▇ ▇▇▇▇▇, San Francisco▇▇▇ ▇▇▇▇, CA 94111▇▇ ▇▇▇▇▇, Attention: Capital MarketsEquity Syndicate Department: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholdersshareholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 1020-KF, Quarterly Report on Form 10-Q, Current Report on Form 86-K or other report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(o) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Affimed N.V.)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at ▇▇the Representatives, c/▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsGlobal Head of Syndicate and c/▇ ▇▇▇▇▇, and to JMP at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100▇▇▇▇ ▇▇▇▇▇, San Francisco▇▇▇ ▇▇▇▇, CA 94111▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Head of Equity Capital Markets: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(q) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Celcuity Inc.)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at ▇▇the Representatives, c/▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsGlobal Head of Syndicate, and to JMP c/o ▇▇▇▇▇ ▇▇▇▇▇▇▇, at ▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100, San Francisco, CA 94111, Attention: Capital Markets[Prospectus Delivery Department]: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other public report filed by the Company with the Commission, FINRA or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (OptiNose, Inc.)

Future Reports to the Representatives. During the period of five three years hereafter hereafter, the Company will furnish or make available to Stifel Leerink Partners LLC, at ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇ and Company, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen LLC at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: Capital Markets, and to JMP at ▇▇▇ ▇▇▇▇▇ and RBC Capital Markets, LLC at ▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, Suite 110010th Floor, San FranciscoNew York, CA 94111, Attention: Capital MarketsNew York 10281: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Immune Design Corp.)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen Citi at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, to ▇▇▇▇▇▇▇ ▇▇▇▇▇ at ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital Markets, Syndicate Department and to JMP Jefferies at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100▇▇▇ ▇▇▇▇, San Francisco, CA 94111▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital Markets: Global Head of Syndicate (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Acadia Healthcare Company, Inc.)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at ▇▇the Representatives, c/▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsGlobal Head of Syndicate and c/o RBCCM, and to JMP at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 11009th Floor, San FranciscoNew York, CA 94111New York 10281, Attention: Capital Markets[●]: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing or furnishing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed or furnished by the Company with the Commission, FINRA or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(A)(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (PubMatic, Inc.)

Future Reports to the Representatives. During the period of five years hereafter the Company will furnish or make available to Stifel at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Syndicate Department and to ▇.▇. ▇▇▇▇▇▇ at ▇.▇. ▇▇▇▇▇▇ Securities LLC, ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital Markets, and to JMP at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100, San Francisco, CA 94111, Attention: Capital Markets: General Counsel: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(q) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Acadia Pharmaceuticals Inc)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at the Representatives, c/o Goldman Sachs & Co. LLC, ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Registration Department; and c/▇ ▇▇▇▇▇▇▇▇▇, at ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital Markets, and to JMP at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100, San Francisco, CA 94111, Attention: Capital MarketsGlobal Head of Syndicate: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Relmada Therapeutics, Inc.)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at the Representatives, c/o Leerink Partners LLC, ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: Capital Markets, and to JMP at ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100, San Francisco, CA 94111, Attention: Syndicate Department, and c/o Evercore Group L.L.C., ▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Equity Capital Markets: Markets (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Aclaris Therapeutics, Inc.)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at ▇▇▇ ▇the Representatives, c/o Cantor F▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇& Co., Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at 4▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Equity Capital Markets, and with copies to JMP at ▇▇▇ Cantor F▇▇▇▇▇▇▇▇▇ & Co., 4▇▇ ▇▇▇▇ ▇▇▇▇▇▇, Suite 1100▇▇▇ ▇▇▇▇, San Francisco, CA 94111▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital Markets: General Counsel: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on E▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Lucid Diagnostics Inc.)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at the Representatives, c/o Wells Fargo Securities, LLC, ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: Equity Syndicate Department and c/▇ ▇▇▇▇▇▇▇▇▇ LLC, ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇, Attention: Capital Markets, and to JMP at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100, San Francisco, CA 94111, Attention: Capital MarketsGlobal Head of Syndicate: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other public report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Bellicum Pharmaceuticals, Inc)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at ▇▇the Representatives, c/▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Global Head of Syndicate; and RBC Capital Markets, and to JMP LLC, at ▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, New York, New York 10281, Attention: ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇, Suite 1100, San Francisco, CA 94111, Attention: Capital Markets: Syndicate Director (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection Section 3 (p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Marinus Pharmaceuticals Inc)

Future Reports to the Representatives. During the period of five years hereafter one year hereafter, the Company will furnish or make available to Stifel the Representatives, c/o Morgan ▇▇▇▇▇▇▇ & Co. LLC, at ▇▇▇ ▇▇▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: SyndicateEquity Syndicate Desk, to Cowen at c/o Citigroup Global Markets Inc., ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital Markets, and to JMP at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100, San Francisco, CA 94111, Attention: Capital Markets: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholdersshareholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stockshares of beneficial interest; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇ or otherwise publicly disseminated.

Appears in 1 contract

Sources: Underwriting Agreement (National Storage Affiliates Trust)

Future Reports to the Representatives. During the period of five three years hereafter hereafter, the Company will furnish or make available to Stifel at ▇▇the Representatives, c/▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital Markets, Global Head of Syndicate and to JMP at ▇▇▇ ▇▇▇▇▇c/o ▇▇▇▇▇ ▇▇▇▇▇▇▇ & Co., Suite 1100▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇, San Francisco▇▇▇▇▇ ▇▇▇▇, CA 94111▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Equity Capital Markets: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other public report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Rigel Pharmaceuticals Inc)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at ▇▇the Representatives, c/▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsGlobal Head of Syndicate, and to JMP at ▇▇▇ ▇▇▇▇▇c/o ▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100at ▇▇▇ ▇▇▇▇ ▇▇▇, San Francisco▇▇▇▇▇ ▇▇▇▇, CA 94111▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Equity Capital Markets: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (TELA Bio, Inc.)

Future Reports to the Representatives. During the period of five three years hereafter hereafter, the Company will furnish or make available to Stifel at ▇▇▇ ▇the Representatives, c/o ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇LLC, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at 5▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsGlobal Head of Syndicate and c/o SVB Leerink, and to JMP at 1301 Avenue of the Americas, 1▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇, Suite 1100, San Francisco, CA 94111, Attention: Capital Markets▇▇▇▇▇: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on E▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Celldex Therapeutics, Inc.)

Future Reports to the Representatives. During the period of five three years hereafter hereafter, the Company will furnish or make available to Stifel at ▇the Representatives, c/o Leerink Partners LLC, ▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700▇▇▇▇ ▇▇▇▇▇, San Francisco▇▇▇▇▇▇, CA 94104▇▇ ▇▇▇▇▇, Attention: SyndicateSyndicate Department and c/▇ ▇▇▇▇▇ and Company, to Cowen LLC, at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital Markets, and to JMP at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100, San Francisco, CA 94111, Attention: Head of Equity Capital Markets: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Celldex Therapeutics, Inc.)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at ▇▇the Representatives, c/▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital Markets, Global Head of Syndicate; and to JMP Leerink Partners LLC at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100▇▇▇▇ ▇▇▇▇▇, San Francisco▇▇▇▇▇▇, CA 94111▇▇ ▇▇▇▇▇, Attention: Capital Markets: ▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇▇, Esq. (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection Section 3 (p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Marinus Pharmaceuticals Inc)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at ▇▇the Representatives, c/▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsGlobal Head of Syndicate; and c/o Stifel, and to JMP at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100▇▇▇▇ ▇▇▇▇▇, San Francisco▇▇▇ ▇▇▇▇, CA 94111▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Equity Capital Markets: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholdersshareholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stockshare capital; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on ▇▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Strongbridge Biopharma PLC)

Future Reports to the Representatives. During the period of five years hereafter hereafter, the Company will furnish or make available to Stifel at ▇▇▇ the Representatives, c/o ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 3700, San Francisco, CA 94104, Attention: Syndicate, to Cowen at 5▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsGlobal Head of Syndicate and c/o Guggenheim Securities, and to JMP at 3▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Suite 1100▇▇▇ ▇▇▇▇, San Francisco, CA 94111▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: Capital MarketsR▇▇▇▇▇ ▇▇▇▇▇▇ and Legal Department: (i) as soon as practicable after the end of each fiscal year, copies of the Annual Report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the year then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA Commission or any securities exchange; and (iii) as soon as available, copies of any report or communication of the Company mailed furnished or made available generally to holders of its capital stock; provided provided, however, that the requirements of this subsection (pSection 3(p) shall be satisfied to the extent the that such reports, statement, communications, financial statements or other documents referenced herein are available on E▇▇▇▇.

Appears in 1 contract

Sources: Underwriting Agreement (Advaxis, Inc.)